Healthcare PE - top shops

Hi all. I’m currently an analyst working in a healthcare group of a bb. I’m curious which funds have the best healthcare practices. Interested in terms of funds that focus strictly on healthcare (I.e a water street) and funds that focus on a range of industries but have a large healthcare focus (I.e a harvest partners). Any insight into which firms are highly regarded in healthcare would be much appreciated.

79 Comments
 

The https://www.privateequityinternational.com/pei-300/</a">PEI 300 list highlights most of the top PE firms in the world and the vast majority of the large ones have strong HC teams. When it comes to more "dedicated" firms, names to come to mind are Apposite Capital (London), G Square Capital (London), GHO Capital (London and probably one of the best in Europe), Astorg (pan-Europe) and MVM Partners (Boston and London)

 

Not to hijack this thread, but does anyone have any familiarity with PE firms that operate in the life sciences space?

Not limiting PE to only mean LBOs either. Growth equity, VC, mezzanine, and royalty funds would be useful too.

 

For pure healthcare Revelstoke is also a good name not on the coasts.

The corporate m&a depending on specific sector of healthcare on both the corporate development and corporate venture arm side of things is extremely built up in the healthcare space as well.

I think healthcare is one of the spaces where there is a decent opportunity to go private equity/VC out of a solid Corp dev type role as well.

 

I have heard terrible things about Revelstoke. Bottom feeder investors who participate in almost every process but submit the lowest offers

 
"Analyst 1 in IB-M&A" I have heard terrible things about Revelstoke. Bottom feeder investors who participate in almost every process but submit the lowest offers

That didn't used to be the case. They have likely overpaid for several assets. It's portfolio is struggling if you look at the failed processes of late.

I'd question their ethics more than anything.

 

A few multi-group funds in Chicago outside of the ones already mentioned: GTCR, MDP, Vistria. All have healthcare groups, but are not pure healthcare.

Regarding RoundTable (already mentioned several times), I knew someone who worked there several years ago. Supposedly has a great culture, but very small team size (~10 people on the investment team) and outside of Chicago (~1 hr commute to the city each way). Fund performance is allegedly top notch (upper quartile). All of this is anecdotal and somewhat dated, so others may have better insights.

 

If you are looking to do healthcare investing long term and had the option between MDP, GTCR, Round Table, Cressy, Water Street and Linden which would you choose and why?

 

Probably MDP, GTCR and Linden first, then Cressey then Water Street / Round Tree MDP / GTCR both good firms and have been around a while. Both HC teams are strong. Linden pays high price for stuff (not like stupid, but for sectors they like which is important for people in HC pre Covid given where valuations were) but overall good people. Their JPM hosting is pretty stylish if that matters. Cressey has some well connected people and has some good companies but in my view more LMM. Water Street bottom feeder type. Don’t know Round Tree - must be pretty LMM

 
Most Helpful

MDP's returns lately have been subpar, some HC investments have performed poorly. Know a few people there currently and their reactions about working there are rather muted. The firm isn't what is used to be.

GTCR is a total sweatshop but returns are solid. Heard better things about their HC group compared to other groups (their fintech team is one of the worst on the street in terms of hours). Pay is fantastic (on par with most MF's)

Cressey is a solid firm, really aggressive on buy/build strategies and de novo platforms. Have been known to pay up in processes, and I disagree with your comment on them being LMM, they are very much a MM player. Hours tend to be a bit longer.

Linden definitely is known to pay stupid multiples (talking mid to high teens). some investments have gone well for them but i imagine the current pandemic is going to cause a lot of their portfolio to be written down in terms of valuations. Hours are sweaty, pay is pretty good I believe. They also have a pretty bad rep in the HC investing community.

Water Street is known for not really playing in auction processes, more focused on proprietary deal sourcing / getting involved in companies with some hair on them. Have done very well recently. Hours can also be a bit longer, pay is on par with other MM firms in Chicago.

Round Table (not Round Tree) is a healthcare focused fund north of Chicago in the burbs. Definitely solid returns, smaller deal teams and less structured deal investment process (work with a guy now who worked at RT for a few years). Culture is solid and hours are fine.

"My name's Ralph Cox, and I'm from where ever's not gonna get me hit"
 

This is really helpful. Thanks a ton. I am also interested in HC PE out of Chicago. Do you have similar insight into a few of the other relevant names from your other post – Waud, Beecken Petty and Flexpoint Ford? Looks like Waud and Flexpoint Ford have recently or are currently raising pretty good sized funds.

 

I'm currently at a HC focused fund (MM)

From my perspective, the MM shops that are well respected are: Five Arrows (Rothschild's PE fund), Frazier, Cressey, Arsenal, Water Street, Round Table, Vistria.

Other names that i'm familiar with that come to mind are: Beecken Petty, WCAS, Waud, Revelstoke, Flexpoint Ford, Parthenon, Audax,

Someone else posted it, but this list is pretty comprehensive: https://www.hcpea.org/current-member-firms

"My name's Ralph Cox, and I'm from where ever's not gonna get me hit"
 

any insight into top strictly healthcare firms in NYC? Most of the strictly healthcare firms I know are in Chicago

 

Does anyone know how Linden’s funds have performed relative to other strictly healthcare funds? It’s interesting how they have been able to increase the size of their fund so quickly

 

Returns at Northlane have been good AFAIK, can't go wrong with them especially with newest fundraise. I also know Martis is one of, or the best in DC that does just healthcare.

 

Apax, Berkshire, Gryphon, GTCR, HIG, Lindsay Goldberg, Madison Dearborn, New Mountain, THL, and Welsh Carson are some names that come to mind based on past processes.

Anecdotally, I have heard good things about the culture at Berkshire. Very well established UMM player that places extremely well into business school (HBS in particular). GTCR has historically performed very well but is a bit on the sweatier side. Junior people are more involved in the IC process than at many other comparable firms. Great comp for Chicago and experience overall. I know that 3/5 associates in one class at Lindsay Goldberg quit a year early either 2-3 years ago so you can try to read into that. Still a reputable fund, as are the other names here. Know multiple people that work at HIG – definitely a sweatshop (great returns, tend to be deep value investors aka bottom feeders) but below market compensation. New Mountain is another top notch firm. They are very active in the HCIT space and seem to employ the buy and build strategy often (and effectively...Equian was an absolute grand slam, like an 8x deal). They just raised a ~$10 billion fund; I'm not surprised by the 50%+ upsize given their success. THL flies under the radar a bit but they seem to have a reasonably robust healthcare practice (looks more pharma services focused). I think they also have a pretty good HBS pipeline (as does New Mountain). Welsh Carson is one of the biggest healthcare names in the UMM space. InnovAge was an amazing deal for them (sold to Apax actually). People here write about good hours – I've heard better than average culture for NYC but the one person I actually know who worked there got absolutely pulverized. 

 

Sequi quis est incidunt et nesciunt. Sed quidem veniam quidem in accusantium dolorum aut. Rerum voluptatem deserunt blanditiis dolorem.

 

Quia quia et fuga praesentium necessitatibus sint. Et sint qui est consectetur voluptatem eius.

Dolore ut voluptatem consectetur earum. Rerum hic in non ullam dolore asperiores rerum. Alias sapiente assumenda quod ut sed omnis dicta. Quisquam quia harum nostrum dolores tenetur error laudantium aliquam.

Quisquam maxime voluptas dicta adipisci et sapiente. Non eos ad incidunt. Qui quaerat nam nisi asperiores qui mollitia.

Atque in qui ut qui similique ut. Recusandae dignissimos nihil earum earum vero. Dolorum cumque dicta expedita quidem ipsam iure. Vitae eligendi eos sint et distinctio.

 

Illum est quia suscipit quia. Voluptatem dolore totam nesciunt quae aut est. Est dignissimos qui sapiente nisi optio optio. Alias ratione facilis dolores omnis.

Repellendus impedit voluptas vitae dolorum. Veniam est repellat et officia rerum omnis.

Voluptates labore et quod autem. Vel fugit ut earum repellat ipsa. Nesciunt et voluptatem distinctio ea voluptatem.

Harum laudantium sequi dicta enim neque est. Nobis laboriosam ut culpa omnis non atque quis. Vitae voluptas est explicabo necessitatibus assumenda ipsa temporibus itaque.

 

Omnis sequi ad vitae expedita. Tempora suscipit quia voluptatem. Et nam et pariatur velit dolor quasi similique. Earum vero voluptates voluptatem eos iure velit. Dicta quaerat accusamus velit quaerat sit qui. Facere quo sint sint commodi autem et.

Quam dolor ex explicabo et id sed nostrum. Dolorem dolorum ducimus doloribus voluptatem saepe non expedita. Ipsum molestiae et vitae et qui ut. Neque itaque magni dolores beatae minus facilis. Non sed et qui quod qui ullam sit. Dolor aliquid tempore voluptas quaerat aut.

Non aliquid animi sapiente nostrum sit. Officiis deleniti natus ut aspernatur. Iste blanditiis aliquam alias ut saepe qui. Quo commodi aut ut ducimus blanditiis.

Career Advancement Opportunities

June 2026 Private Equity

  • The Riverside Company 99.6%
  • KKR (Kohlberg Kravis Roberts) 99.2%
  • Blackstone Group 98.9%
  • Warburg Pincus 98.5%
  • Bain Capital 98.1%

Overall Employee Satisfaction

June 2026 Private Equity

  • KKR (Kohlberg Kravis Roberts) 99.6%
  • The Riverside Company 99.2%
  • Ardian 98.9%
  • Blackstone Group 98.5%
  • Starwood Capital Group 98.1%

Professional Growth Opportunities

June 2026 Private Equity

  • Bain Capital 99.6%
  • The Riverside Company 99.2%
  • Blackstone Group 98.9%
  • Starwood Capital Group 98.5%
  • KKR (Kohlberg Kravis Roberts) 98.1%

Total Avg Compensation

June 2026 Private Equity

  • Principal (9) $653
  • Director/MD (24) $547
  • Vice President (97) $363
  • 3rd+ Year Associate (104) $281
  • 2nd Year Associate (234) $272
  • 1st Year Associate (411) $229
  • 3rd+ Year Analyst (33) $157
  • 2nd Year Analyst (95) $134
  • 1st Year Analyst (271) $124
  • Intern/Summer Associate (37) $80
  • Intern/Summer Analyst (351) $61
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
kanon's picture
kanon
99.0
5
DrApeman's picture
DrApeman
98.9
6
dosk17's picture
dosk17
98.9
7
CompBanker's picture
CompBanker
98.9
8
GameTheory's picture
GameTheory
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”